{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:52:10Z","timestamp":1775584330562,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31702210"],"award-info":[{"award-number":["31702210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31772747"],"award-info":[{"award-number":["31772747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2017YFD0500103"],"award-info":[{"award-number":["2017YFD0500103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ijbiomac.2019.03.161","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T04:02:59Z","timestamp":1553313779000},"page":"925-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitro"],"prefix":"10.1016","volume":"131","author":[{"given":"Shouwen","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieying","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maopeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penfeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linzhu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijbiomac.2019.03.161_bb0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr Gene Ther"},{"issue":"12","key":"10.1016\/j.ijbiomac.2019.03.161_bb0010","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2019.03.161_bb0015","first-page":"163","article-title":"Single-cycle adenovirus vectors in the current vaccine landscape","volume":"17","author":"Barry","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gene.2018.08.069","article-title":"A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy","volume":"679","author":"Stepanenko","year":"2018","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.03.161_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2019.03.161_bb0030","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1128\/jvi.71.4.3293-3298.1997","article-title":"A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging","volume":"71","author":"Parks","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0035","first-page":"363","article-title":"Adenovirus-based expression vectors and recombinant vaccines","volume":"20","author":"Graham","year":"1992","journal-title":"Biotechnology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.03.161_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-0270(02)00295-9","article-title":"Transduction of bovine adrenal chromaffin cells using a recombinant adenovirus expressing GFP","volume":"122","author":"Li","year":"2002","journal-title":"J. Neurosci. Methods"},{"issue":"7","key":"10.1016\/j.ijbiomac.2019.03.161_bb0045","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JVI.03258-15","article-title":"A recombinant adenovirus expressing ovine interferon tau prevents influenza virus-induced lethality in mice","volume":"90","author":"Martin","year":"2016","journal-title":"J. Virol."},{"issue":"50","key":"10.1016\/j.ijbiomac.2019.03.161_bb0050","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1016\/j.vaccine.2012.09.058","article-title":"Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform","volume":"30","author":"Gabitzsch","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ijbiomac.2019.03.161_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181578","article-title":"Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens","volume":"12","author":"Tan","year":"2017","journal-title":"PLoS One"},{"issue":"47","key":"10.1016\/j.ijbiomac.2019.03.161_bb0060","doi-asserted-by":"crossref","first-page":"19940","DOI":"10.1073\/pnas.0907898106","article-title":"Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1","volume":"106","author":"Benlahrech","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"45","key":"10.1016\/j.ijbiomac.2019.03.161_bb0065","doi-asserted-by":"crossref","first-page":"32184","DOI":"10.1074\/jbc.M113.514356","article-title":"Interferon-induced transmembrane protein 3 is a type II transmembrane protein","volume":"288","author":"Bailey","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.03.161_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003124","article-title":"IFITM proteins restrict viral membrane hemifusion","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.ijbiomac.2019.03.161_bb0075","article-title":"The dispanins: a novel gene family of ancient origin that contains 14 human members","volume":"7","author":"S\u00e4llman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2164-13-155","article-title":"Evolution of vertebrate interferon inducible transmembrane proteins","volume":"13","author":"Hickford","year":"2012","journal-title":"BMC Genomics"},{"issue":"43","key":"10.1016\/j.ijbiomac.2019.03.161_bb0085","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1074\/jbc.M115.657346","article-title":"The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry","volume":"290","author":"Narayana","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.03.161_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11262-017-1509-0","article-title":"First molecular detection of porcine circovirus type 3 in dogs in China","volume":"54","author":"Zhang","year":"2018","journal-title":"Virus Genes"},{"issue":"11","key":"10.1016\/j.ijbiomac.2019.03.161_bb0095","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.celrep.2016.05.074","article-title":"The IFITMs inhibit Zika virus replication","volume":"15","author":"Savidis","year":"2016","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2019.03.161_bb0100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/tra.12416","article-title":"Alphavirus restriction by IFITM proteins","volume":"17","author":"Weston","year":"2016","journal-title":"Traffic"},{"issue":"6","key":"10.1016\/j.ijbiomac.2019.03.161_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01535-17","article-title":"Identification of residues controlling restriction versus enhancing activities of IFITM proteins on entry of human coronaviruses","volume":"92","author":"Zhao","year":"2018","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2019.03.161_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156739","article-title":"Nonhuman primate IFITM proteins are potent inhibitors of HIV and SIV","volume":"11","author":"Wilkins","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijbiomac.2019.03.161_bb0115","first-page":"372","article-title":"Establishment of A549 cell stain stably expressing human IFITM3 and its inhibition to avian influenza virus infection","volume":"32","author":"Jiang","year":"2016","journal-title":"Chin. J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.03.161_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12977-017-0377-y","article-title":"More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins","volume":"14","author":"Shi","year":"2017","journal-title":"Retrovirology"},{"issue":"11","key":"10.1016\/j.ijbiomac.2019.03.161_bb0125","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.15252\/embr.201642771","article-title":"Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity","volume":"17","author":"Compton","year":"2016","journal-title":"EMBO Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2019.03.161_bb0130","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","article-title":"IFITM-family proteins: the cell's first line of antiviral defense","volume":"1","author":"Bailey","year":"2014","journal-title":"Annu. Rev. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2019.03.161_bb0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41589-018-0213-2","article-title":"IFITM3 directly engages and shuttles incoming virus particles to lysosomes","volume":"15","author":"Spence","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2019.03.161_bb0145","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.15252\/embj.201695597","article-title":"Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells","volume":"36","author":"Monel","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2013.11.004","article-title":"IFITM proteins-cellular inhibitors of viral entry","volume":"4","author":"Smith","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"7395","key":"10.1016\/j.ijbiomac.2019.03.161_bb0155","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","article-title":"IFITM3 restricts the morbidity and mortality associated with influenza","volume":"484","author":"Everitt","year":"2012","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.ijbiomac.2019.03.161_bb0160","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1128\/JVI.00655-16","article-title":"The interferon-stimulated gene IFITM3 restricts infection and pathogenesis of arthritogenic and encephalitic alphaviruses","volume":"90","author":"Poddar","year":"2016","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2019.03.161_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002337","article-title":"IFITM3 inhibits influenza A virus infection by preventing cytosolic entry","volume":"7","author":"Feeley","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.antiviral.2014.06.008","article-title":"Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo","volume":"109","author":"Xu","year":"2014","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.03.161_bb0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri3344","article-title":"The broad-spectrum antiviral functions of IFIT and IFITM proteins","volume":"13","author":"Diamond","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2019.03.161_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/v11020126","article-title":"Antiviral Role of IFITM Proteins in Classical Swine Fever Virus Infection","volume":"11","author":"Li","year":"2019","journal-title":"Viruses"},{"issue":"24","key":"10.1016\/j.ijbiomac.2019.03.161_bb0185","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.jmb.2013.09.024","article-title":"IFITMs restrict the replication of multiple pathogenic viruses","volume":"425","author":"Perreira","year":"2013","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2019.03.161_bb0190","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15252\/embr.201744100","article-title":"IFITM3 requires an amphipathic helix for antiviral activity","volume":"18","author":"Chesarino","year":"2017","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.03.161_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35755-z","article-title":"Efficacy of a T cell-biased adenovirus vector as a Zika virus vaccine","volume":"8","author":"Bullard","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virusres.2014.12.015","article-title":"Construction and characterization of novel fowlpox virus shuttle vectors","volume":"197","author":"Du","year":"2015","journal-title":"Virus Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2019.03.161_bb0205","doi-asserted-by":"crossref","first-page":"e476s","DOI":"10.6061\/clinics\/2018\/e476s","article-title":"Improving adenoviral vectors and strategies for prostate cancer gene therapy","volume":"73","author":"Tamura","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2018.02.002","article-title":"Recent advances in viral vectors in veterinary vaccinology","volume":"29","author":"Baron","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0014-4827(60)90355-4","article-title":"Significance of cytopathic effects observed during the growth of adenovirus","volume":"21","author":"Armstrong","year":"1960","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijbiomac.2019.03.161_bb0220","article-title":"Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals","volume":"4","author":"Zhang","year":"2013","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2019.03.161_bb0225","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/pharmaceutics3030338","article-title":"Adenovirus vector-derived VA-RNA-mediated innate immune responses","volume":"3","author":"Machitani","year":"2011","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2019.03.161_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019304222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019304222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:56:44Z","timestamp":1775581004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813019304222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":46,"alternative-id":["S0141813019304222"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.03.161","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitro","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.03.161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}